VP

venBio Partners Portfolio holdings

AUM $115M
1-Year Est. Return 33.99%
This Quarter Est. Return
1 Year Est. Return
-33.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$124M
AUM Growth
-$47.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$1.66M
2
+$963K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHVS icon
1
Pharvaris
PHVS
$1.41B
$67.3M 54.5%
4,289,304
ALMS
2
Alumis Inc
ALMS
$480M
$17.1M 13.85%
2,787,398
HRMY icon
3
Harmony Biosciences
HRMY
$1.49B
$16.2M 13.14%
489,194
-50,000
SLRN
4
DELISTED
ACELYRIN
SLRN
$9.4M 7.61%
3,806,410
ALXO icon
5
ALX Oncology
ALXO
$88.4M
$6.04M 4.89%
9,699,925
LYEL icon
6
Lyell Immunopharma
LYEL
$327M
$3.82M 3.09%
355,110
ARTV
7
Artiva Biotherapeutics
ARTV
$67.7M
$3.6M 2.91%
1,198,975
-320,996